Richard J. Daly - 26 Aug 2025 Form 4 Insider Report for CATALYST PHARMACEUTICALS, INC. (CPRX)

Role
President and CEO, Director
Signature
/s/ Richard J. Daly
Issuer symbol
CPRX
Transactions as of
26 Aug 2025
Net transactions value
-$361,641
Form type
4
Filing time
28 Aug 2025, 17:00:04 UTC
Previous filing
03 Jun 2025
Next filing
24 Nov 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Daly Richard J President and CEO, Director 355 ALHAMBRA CIRCLE, SUITE 801, CORAL GABLES /s/ Richard J. Daly 28 Aug 2025 0001635393

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CPRX Common stock, par value $0.001 per share Options Exercise $112,000 +50,000 +25% $2.24 249,764 26 Aug 2025 Direct
transaction CPRX Common stock, par value $0.001 per share Sale $473,641 -22,970 -9.2% $20.62 226,794 26 Aug 2025 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CPRX Options to purchase common stock Options Exercise $0 -50,000 -2.2% $0.000000 2,184,753 26 Aug 2025 Common Stock 50,000 $2.24 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares were sold on the open market to fund the exercise price and tax withholding due from Mr. Daly on the exercise of the 50,000 stock options reported on Table II.
F2 Derivative securities vested in three annual tranches beginning on December 19, 2019.